Literature DB >> 28705806

Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges.

Sandrina Maertin1,2,3, Jason M Elperin1,2, Ethan Lotshaw1,2, Matthias Sendler3, Steven D Speakman1,2, Kazuki Takakura1,2, Benjamin M Reicher1,2, Olga A Mareninova1,2, Paul J Grippo4, Julia Mayerle3,5, Markus M Lerch3, Anna S Gukovskaya6,2.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) displays extensive and poorly vascularized desmoplastic stromal reaction, and therefore, pancreatic cancer (PaCa) cells are confronted with nutrient deprivation and hypoxia. Here, we investigate the roles of autophagy and metabolism in PaCa cell adaptation to environmental stresses, amino acid (AA) depletion, and hypoxia. It is known that in healthy cells, basal autophagy is at a low level, but it is greatly activated by environmental stresses. By contrast, we find that in PaCa cells, basal autophagic activity is relatively high, but AA depletion and hypoxia activate autophagy only weakly or not at all, due to their failure to inhibit mechanistic target of rapamycin. Basal, but not stress-induced, autophagy is necessary for PaCa cell proliferation, and AA supply is even more critical to maintain PaCa cell growth. To gain insight into the underlying mechanisms, we analyzed the effects of autophagy inhibition and AA depletion on PaCa cell metabolism. PaCa cells display mixed oxidative/glycolytic metabolism, with oxidative phosphorylation (OXPHOS) predominant. Both autophagy inhibition and AA depletion dramatically decreased OXPHOS; furthermore, pharmacologic inhibitors of OXPHOS suppressed PaCa cell proliferation. The data indicate that the maintenance of OXPHOS is a key mechanism through which autophagy and AA supply support PaCa cell growth. We find that the expression of oncogenic activation mutation in GTPase Kras markedly promotes basal autophagy and stimulates OXPHOS through an autophagy-dependent mechanism. The results suggest that approaches aimed to suppress OXPHOS, particularly through limiting AA supply, could be beneficial in treating PDAC.NEW & NOTEWORTHY Cancer cells in the highly desmoplastic pancreatic ductal adenocarcinoma confront nutrient [i.e., amino acids (AA)] deprivation and hypoxia, but how pancreatic cancer (PaCa) cells adapt to these conditions is poorly understood. This study provides evidence that the maintenance of mitochondrial function, in particular, oxidative phosphorylation (OXPHOS), is a key mechanism that supports PaCa cell growth, both in normal conditions and under the environmental stresses. OXPHOS in PaCa cells critically depends on autophagy and AA supply. Furthermore, the oncogenic activation mutation in GTPase Kras upregulates OXPHOS through an autophagy-dependent mechanism.

Entities:  

Keywords:  autophagy; cell growth; cell metabolism; mitochondria; pancreatic cancer

Mesh:

Substances:

Year:  2017        PMID: 28705806      PMCID: PMC5792215          DOI: 10.1152/ajpgi.00138.2017

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  57 in total

1.  The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.

Authors:  Claudia Nitsche; Mouad Edderkaoui; Ryan M Moore; Guido Eibl; Noriyuki Kasahara; Janet Treger; Paul J Grippo; Julia Mayerle; Markus M Lerch; Anna S Gukovskaya
Journal:  Gastroenterology       Date:  2011-10-29       Impact factor: 22.682

Review 2.  Regulation of mTORC1 by PI3K signaling.

Authors:  Christian C Dibble; Lewis C Cantley
Journal:  Trends Cell Biol       Date:  2015-07-06       Impact factor: 20.808

3.  Methods in mammalian autophagy research.

Authors:  Noboru Mizushima; Tamotsu Yoshimori; Beth Levine
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

4.  Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy.

Authors:  K Izuishi; K Kato; T Ogura; T Kinoshita; H Esumi
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

5.  Human pancreatic duct epithelial cell model for KRAS transformation.

Authors:  Nikolina Radulovich; Jia-ying Qian; Ming-Sound Tsao
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

6.  Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.

Authors:  Carmen Guerra; Alberto J Schuhmacher; Marta Cañamero; Paul J Grippo; Lena Verdaguer; Lucía Pérez-Gallego; Pierre Dubus; Eric P Sandgren; Mariano Barbacid
Journal:  Cancer Cell       Date:  2007-03       Impact factor: 31.743

Review 7.  Regulation of Autophagy By Signaling Through the Atg1/ULK1 Complex.

Authors:  Daniel Papinski; Claudine Kraft
Journal:  J Mol Biol       Date:  2016-04-06       Impact factor: 5.469

Review 8.  The ULK1 complex: sensing nutrient signals for autophagy activation.

Authors:  Pui-Mun Wong; Cindy Puente; Ian G Ganley; Xuejun Jiang
Journal:  Autophagy       Date:  2013-01-07       Impact factor: 16.016

Review 9.  Kras as a key oncogene and therapeutic target in pancreatic cancer.

Authors:  Meredith A Collins; Marina Pasca di Magliano
Journal:  Front Physiol       Date:  2014-01-21       Impact factor: 4.566

Review 10.  Targeting cancer cell metabolism in pancreatic adenocarcinoma.

Authors:  Romain Cohen; Cindy Neuzillet; Annemilaï Tijeras-Raballand; Sandrine Faivre; Armand de Gramont; Eric Raymond
Journal:  Oncotarget       Date:  2015-07-10
View more
  8 in total

1.  Differences of basic and induced autophagic activity between K562 and K562/ADM cells.

Authors:  Feifei Wang; Jing Chen; Zhewen Zhang; Juan Yi; Minmin Yuan; Mingyan Wang; Na Zhang; Xuemin Qiu; Hulai Wei; Ling Wang
Journal:  Intractable Rare Dis Res       Date:  2017-11

Review 2.  Regulation and function of autophagy in pancreatic cancer.

Authors:  Jingbo Li; Xin Chen; Rui Kang; Herbert Zeh; Daniel J Klionsky; Daolin Tang
Journal:  Autophagy       Date:  2020-11-20       Impact factor: 16.016

3.  DDIT4 Novel Mutations in Pancreatic Cancer.

Authors:  Fadian Ding; Xiaoping Hong; Xiangqun Fan; Shirong Huang; Wei Lian; Xingting Chen; Qicai Liu; Youting Chen; Feng Gao
Journal:  Gastroenterol Res Pract       Date:  2021-04-30       Impact factor: 2.260

4.  Natural Compound Methyl Protodioscin Suppresses Proliferation and Inhibits Glycolysis in Pancreatic Cancer.

Authors:  LianYu Chen; Chien-Shan Cheng; HuiFeng Gao; Ling Zhan; FengJiao Wang; Chao Qu; Ye Li; Peng Wang; Hao Chen; ZhiQiang Meng; LuMing Liu; HaiFeng Chen; Zhen Chen
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-15       Impact factor: 2.629

Review 5.  Metabolism of pancreatic cancer: paving the way to better anticancer strategies.

Authors:  Cheng Qin; Gang Yang; Jinshou Yang; Bo Ren; Huanyu Wang; Guangyu Chen; Fangyu Zhao; Lei You; Weibin Wang; Yupei Zhao
Journal:  Mol Cancer       Date:  2020-03-02       Impact factor: 27.401

Review 6.  Targeting hypoxic tumor microenvironment in pancreatic cancer.

Authors:  Jinxin Tao; Gang Yang; Wenchuan Zhou; Jiangdong Qiu; Guangyu Chen; Wenhao Luo; Fangyu Zhao; Lei You; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  J Hematol Oncol       Date:  2021-01-13       Impact factor: 17.388

Review 7.  Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review).

Authors:  Michal Zuzčák; Jan Trnka
Journal:  Int J Oncol       Date:  2022-06-22       Impact factor: 5.884

8.  Synchronous effects of targeted mitochondrial complex I inhibitors on tumor and immune cells abrogate melanoma progression.

Authors:  Mahmoud AbuEid; Donna M McAllister; Laura McOlash; Megan Cleland Harwig; Gang Cheng; Donovan Drouillard; Kathleen A Boyle; Micael Hardy; Jacek Zielonka; Bryon D Johnson; R Blake Hill; Balaraman Kalyanaraman; Michael B Dwinell
Journal:  iScience       Date:  2021-05-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.